Nutrition, Metabolism & Cardiovascular Diseases
Volume 19, Issue 11 , Pages 789-796 , December 2009

Fibrinogen kinetics and protein turnover in hypertension: Effects of insulin

  • E. Kiwanuka

      Affiliations

    • Metabolism Division, Policlinico Universitario, via Giustiniani 2, 35128 Padova, Italy
    • ,
  • A. Coracina

      Affiliations

    • Metabolism Division, Policlinico Universitario, via Giustiniani 2, 35128 Padova, Italy
    • ,
  • M. Vettore

      Affiliations

    • Metabolism Division, Policlinico Universitario, via Giustiniani 2, 35128 Padova, Italy
    • ,
  • A. Semplicini

      Affiliations

    • Internal Medicine, Department of Clinical and Experimental Medicine, Policlinico Universitario, via Giustiniani 2, 35128 Padova, Italy
    • ,
  • M. Zaramella

      Affiliations

    • Metabolism Division, Policlinico Universitario, via Giustiniani 2, 35128 Padova, Italy
    • ,
  • R. Millioni

      Affiliations

    • Metabolism Division, Policlinico Universitario, via Giustiniani 2, 35128 Padova, Italy
    • ,
  • L. Puricelli

      Affiliations

    • Metabolism Division, Policlinico Universitario, via Giustiniani 2, 35128 Padova, Italy
    • ,
  • M.R. Baiocchi

      Affiliations

    • Internal Medicine, Department of Medical and Surgical Sciences, Policlinico Universitario, via Giustiniani 2, 35128 Padova, Italy
    • ,
  • P. Tessari

      Affiliations

    • Metabolism Division, Policlinico Universitario, via Giustiniani 2, 35128 Padova, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 049 8211748; fax: +39 049 8754179.

Received 1 October 2008 ,Revised 13 January 2009 ,Accepted 19 January 2009.

References 

  1. Wilhemsen L, Svardsuss K, Korsan-Bengsten K. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501–505
  2. Grover SA, Hemmelgarn B, Joseph L, Milot A, Tremblay G. The role of global risk assessment in hypertension therapy. Can J Cardiol. 2006;22:606–613
  3. Catena C, Novello M, Lapenna R, Baroselli S, Colussi G, Nadalini E, et al. New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a). J Hypertens. 2005;23:1617–1631
  4. Engstrom G, Janzon L, Berglund G, Lind P, Stavenow L, Hedblad B, et al. Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol. 2002;22:2054–2058
  5. Lane JS, Vittinghoff E, Lane KT, Hiramoto JS, Messina LM. Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey 1999–2002. J Vasc Surg. 2006;44:319–324
  6. Engstrom G, Hedblad B, Janzon L, Lindgarde F. Fatality of acute coronary events in relation to hypertension and low-grade inflammation: a population-based cohort study. J Hum Hypertens. 2006;20:581–586
  7. Tessari P, Inchiostro S, Biolo G, Trevisan R, Fantin G, Marescotti MC, et al. Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition. J Clin Invest. 1987;79:1062–1069
  8. De Feo P, Volpi E, Lucidi P, Cruciani G, Reboldi G, Siepi D, et al. Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans. Diabetes. 1993;42:995–1002
  9. Barazzoni R, Kiwanuka E, Zanetti M, Cristini M, Vettore M, Tessari P. Insulin acutely increases fibrinogen production in individuals with type 2 diabetes but not in individuals without diabetes. Diabetes. 2003;52:1851–1856
  10. Mertens I, Van Gaal LF. New International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment panel III (NCEP-ATPIII) criteria and the involvement of hemostasis and fibrinolysis in the metabolic syndrome. J Thromb Haemost. 2006;4:1164–1166
  11. Devaraj S, Rosenson RS, Jialal I. Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status. Endocrinol Metab Clin North Am. 2004;33:431–453
  12. Haller M, Akbulut C, Brechtelsbauer H, Fett W, Briegel J, Finsterer U, et al. Determination of plasma volume with indocyanine green in man. Life Sci. 1993;53:1597–1604
  13. Hoffmann JJML, Verhappen MAL. Automated nephelometry of fibrinogen: analytical performance and observations during thrombotic therapy. Clin Chem. 1998;34:2135–2140
  14. Schwenk WF, Berg PJ, Beaufrere B, Miles JM, Haymond MW. Use of t-butyl-dimethylsilylation in the GC/MS analysis of physiologic compounds found in plasma using electron impact ionization. Anal Biochem. 1984;141:101–109
  15. Wolfe RR. Radioactive and stable isotope tracers in biomedicine. Principles and practice of kinetics analysis. New York: Wiley-Liss; 1992;pp. 62–70
  16. Schwenk WF, Beaufrere B, Haymond MW. Use of reciprocal pool specific activities to model leucine metabolism in man. Am J Physiol. 1985;249:E646–E650
  17. Ferrannini E, Haffner SM, Stern MP. Essential hypertension: an insulin-resistant state. J Cardiovasc Pharmacol. 1990;15(Suppl. 5):S18–S25
  18. Kurl S, Laukkanen JA, Niskanen L, Laaksonen D, Sivenius J, Nyyssonen K, et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke. 2006;37:806–811
  19. Tessari P, Kiwanuka E, Millioni R, Vettore M, Puricelli L, Zanetti M, et al. Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria. Diabetes Care. 2006;29:323–328
  20. Amagasa H, Okazaki M, Iwai S, Kumai T, Kobayashi S, Oguchi K. Enhancement of the coagulation system in spontaneously hypertensive and hyperlipidemic rats. J Atheroscler Thromb. 2005;12:191–198
  21. Voisin L, Breuille D, Ruot B, Ralliere C, Rambourdin F, Dalle M, et al. Cytokine modulation by PX differently affects specific acute phase proteins during sepsis in rats. Am J Physiol. 1998;275:R1412–R1419
  22. Garanty-Bogacka B, Syrenicz M, Syrenicz A, Gebala A, Lulka D, Walczak M. Serum markers of inflammation and endothelial activation in children with obesity-related hypertension. Neuro Endocrinol Lett. 2005;26:242–246
  23. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 1997;40:1286–1292
  24. Festa A, D'Agostino R, Tracy RP, Haffner SM. The Insulin Resistance Atherosclerosis Study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2002;51:1131–1137
  25. Soop M, Duxbury H, Agwunobi AO, Gibson JM, Hopkins SJ, Childs C, et al. Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. Am J Physiol Endocrinol Metab. 2002;282:E1276–E1285
  26. Dandona P, Chaudhuri A, Ghanim H, Mohanty P. Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. Am J Cardiol. 2007;99:15B–26B
  27. Tentolouris N, Liatis S, Katsilambros N. Sympathetic system activity in obesity and metabolic syndrome. Ann N Y Acad Sci. 2006;1083:129–152
  28. O'Riordain MG, Ross JA, Fearon KCH, Maingay J, Farouk M, Garden J, et al. Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am J Physiol Endocrinol Metab. 1995;269:E323–E330
  29. Ferri C, Desideri G, Baldoncini R, Bellini C, De Angelis C, Mazzocchi C, et al. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes. 1998;47(4):660–667
  30. Haller H, Park JK, Dragun D, Lippoldt A, Luft FC. Leukocyte infiltration and ICAM-1 expression in two-kidney one-clip hypertension. Nephrol Dial Transplant. 1997;12(5):899–903
  31. Goonasekera CD, Shah V, Rees DD, Dillon MJ. Vascular endothelial cell activation associated with increased plasma asymmetric dimethyl arginine in children and young adults with hypertension: a basis for atheroma?. Blood Press. 2000;9(1):16–21
  32. Boulbou MS, Koukoulis GN, Makri ED, Petinaki EA, Gourgoulianis KI, Germenis AE. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension. Int J Cardiol. 2005;98(1):39–44
  33. Cardillo C, Mettimano M, Mores N, Koh KK, Campia U, Panza JA. Plasma levels of cell adhesion molecules during hyperinsulinemia and modulation of vasoactive mediators. Vasc Med. 2004;9(3):185–188
  34. Blüher M, Unger R, Rassoul F, Richter V, Paschke R. Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or type II diabetes. Diabetologia. 2002;45(2):210–216
  35. Madonna R, Pandolfi A, Massaro M, Consoli A, De Caterina R. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia. 2004;47:532–536
  36. Garanty-Bogacka B, Syrenicz M, Syrenicz A, Gebala A, Walczak M. Relation of acute-phase reaction and endothelial activation to insulin resistance and adiposity in obese children and adolescents. Neuro Endocrinol Lett. 2005;26(5):473–479
  37. Lee S, Gungor N, Bacha F, Arslanian S. Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth. Diabetes Care. 2007;30(8):2091–2097Epub 2007 May 2. Erratum in: Diabetes Care. 2007 Oct;30(10):2763]
  38. Fu A, Nair KS. Age effect on fibrinogen and albumin synthesis in humans. Am J Physiol. 1998 Dec;275(6 Pt. 1):E1023–E1030
  39. Jacquemin B, Antoniades C, Nyberg F, Plana E, Müller M, Greven S, et al. Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study. J Am Coll Cardiol. 2008;52(11):941–952

PII: S0939-4753(09)00013-1

doi: 10.1016/j.numecd.2009.01.005

Nutrition, Metabolism & Cardiovascular Diseases
Volume 19, Issue 11 , Pages 789-796 , December 2009

Article Tools

* Image Usage & Resolution